192 related articles for article (PubMed ID: 31816181)
1. Flow cytometry aneuploidy and cell cycle indexing as a possible tool for differentiating between CD10
Azoulay D; Cohen HI; Dementiev E; Eshel E; Akria L; Shaoul E; Horowitz N
Cytometry B Clin Cytom; 2020 Sep; 98(5):449-453. PubMed ID: 31816181
[TBL] [Abstract][Full Text] [Related]
2. CD10 and BCL-6 expression in paraffin sections of normal lymphoid tissue and B-cell lymphomas.
Dogan A; Bagdi E; Munson P; Isaacson PG
Am J Surg Pathol; 2000 Jun; 24(6):846-52. PubMed ID: 10843287
[TBL] [Abstract][Full Text] [Related]
3. Comparison of genetic aberrations in CD10+ diffused large B-cell lymphoma and follicular lymphoma by comparative genomic hybridization and tissue-fluorescence in situ hybridization.
Zhang X; Karnan S; Tagawa H; Suzuki R; Tsuzuki S; Hosokawa Y; Morishima Y; Nakamura S; Seto M
Cancer Sci; 2004 Oct; 95(10):809-14. PubMed ID: 15504248
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of interphase fluorescence in situ hybridization for the t(14;18)(q32;q21) translocation in the diagnosis of follicular lymphoma on fine-needle aspirates: a comparison with flow cytometry immunophenotyping.
Gong Y; Caraway N; Gu J; Zaidi T; Fernandez R; Sun X; Huh YO; Katz RL
Cancer; 2003 Dec; 99(6):385-93. PubMed ID: 14681948
[TBL] [Abstract][Full Text] [Related]
5. Contribution of immunophenotype to the investigation and differential diagnosis of Burkitt lymphoma, double-hit high-grade B-cell lymphoma, and single-hit MYC-rearranged diffuse large B-cell lymphoma.
Tsagarakis NJ; Papadhimitriou SI; Pavlidis D; Liapis K; Gortzolidis G; Kostopoulos IV; Marinakis T; Paterakis G
Cytometry B Clin Cytom; 2020 Sep; 98(5):412-420. PubMed ID: 32497402
[TBL] [Abstract][Full Text] [Related]
6. Immunophenotypic and genotypic markers of follicular center cell neoplasia in diffuse large B-cell lymphomas.
King BE; Chen C; Locker J; Kant J; Okuyama K; Falini B; Swerdlow SH
Mod Pathol; 2000 Nov; 13(11):1219-31. PubMed ID: 11106080
[TBL] [Abstract][Full Text] [Related]
7. Flow Cytometry in the Differential Diagnosis of CD10-Positive Nodal Lymphomas.
Sorigue M; Santos-Gomez M; Comes M; Raya M; Vergara S; Tapia G; Navarro JT; Morales-Indiano C; Junca J
Lab Med; 2020 Jul; 51(4):385-393. PubMed ID: 31834933
[TBL] [Abstract][Full Text] [Related]
8. Differentiating between Burkitt lymphoma and CD10+ diffuse large B-cell lymphoma: the role of commonly used flow cytometry cell markers and the application of a multiparameter scoring system.
McGowan P; Nelles N; Wimmer J; Williams D; Wen J; Li M; Ewton A; Curry C; Zu Y; Sheehan A; Chang CC
Am J Clin Pathol; 2012 Apr; 137(4):665-70. PubMed ID: 22431545
[TBL] [Abstract][Full Text] [Related]
9. Coexpression of Bcl-6 and CD10 in diffuse large B-cell lymphomas: significance of Bcl-6 expression patterns in identifying germinal center B-cell lymphoma.
Ree HJ; Yang WI; Kim CW; Huh J; Lee SS; Cho EY; Ko YH; Charney D
Hum Pathol; 2001 Sep; 32(9):954-62. PubMed ID: 11567225
[TBL] [Abstract][Full Text] [Related]
10. A novel flow cytometric antibody panel for distinguishing Burkitt lymphoma from CD10+ diffuse large B-cell lymphoma.
Schniederjan SD; Li S; Saxe DF; Lechowicz MJ; Lee KL; Terry PD; Mann KP
Am J Clin Pathol; 2010 May; 133(5):718-26. PubMed ID: 20395518
[TBL] [Abstract][Full Text] [Related]
11. Significance of CD10 protein expression in the diagnostics of follicular lymphoma: A comparison of conventional immunohistochemistry with flow cytometry supported by the establishment of BCL2 and BCL6 rearrangements.
Szumera-Ciećkiewicz A; Rymkiewicz G; Sokół K; Paszkiewicz-Kozik E; Borysiuk A; Poleszczuk J; Bachnio K; Bystydzienski Z; Woroniecka R; Grygalewicz B; Kotarska M; Stańczak M; Owczarek D; Pytlak B; Prochorec-Sobieszek M; Walewski J
Int J Lab Hematol; 2020 Aug; 42(4):453-463. PubMed ID: 32364682
[TBL] [Abstract][Full Text] [Related]
12. Flow cytometry using the monoclonal antibody CD10-Pe/Cy5 is a useful tool to identify follicular lymphoma cells.
Bellido M; Rubiol E; Ubeda J; López O; Estivill C; Carnicer M; Muñoz L; Bordes R; Sierra J; Nomdedéu J
Eur J Haematol; 2001 Feb; 66(2):100-6. PubMed ID: 11168517
[TBL] [Abstract][Full Text] [Related]
13. The importance of CD39, CD43, CD81, and CD95 expression for differentiating B cell lymphoma by flow cytometry.
Cardoso CC; Auat M; Santos-Pirath IM; Rudolf-Oliveira RCM; da Silva JP; Lange BG; Siegel D; de Moraes ACR; Del Moral JAG; Santos-Silva MC
Cytometry B Clin Cytom; 2018 May; 94(3):451-458. PubMed ID: 28509416
[TBL] [Abstract][Full Text] [Related]
14. CD10 expression in follicular lymphoma and large cell lymphoma is different from that of reactive lymph node follicles.
Almasri NM; Iturraspe JA; Braylan RC
Arch Pathol Lab Med; 1998 Jun; 122(6):539-44. PubMed ID: 9625422
[TBL] [Abstract][Full Text] [Related]
15. CD5-positive diffuse large B cell lymphoma arising from a CD5-positive follicular lymphoma.
Vassallo J; Bousquet M; Quelen C; Al Saati T; Delsol G; Brousset P
J Clin Pathol; 2007 May; 60(5):573-5. PubMed ID: 17513519
[TBL] [Abstract][Full Text] [Related]
16. CD10 down expression in follicular lymphoma correlates with gastrointestinal lesion involving the stomach and large intestine.
Ohnishi N; Takata K; Miyata-Takata T; Sato Y; Tari A; Gion Y; Noujima-Harada M; Taniguchi K; Tabata T; Nagakita K; Omote S; Takahata H; Iwamuro M; Okada H; Maeda Y; Yanai H; Yoshino T
Cancer Sci; 2016 Nov; 107(11):1687-1695. PubMed ID: 27513891
[TBL] [Abstract][Full Text] [Related]
17. Clinicopathological prognostic indicators in 107 patients with diffuse large B-cell lymphoma transformed from follicular lymphoma.
Maeshima AM; Taniguchi H; Fukuhara S; Maruyama D; Kim SW; Watanabe T; Kobayashi Y; Tobinai K; Tsuda H
Cancer Sci; 2013 Jul; 104(7):952-7. PubMed ID: 23521357
[TBL] [Abstract][Full Text] [Related]
18. [Diffuse large B-cell lymphoma developed newly after 9-year remission of a follicular lymphoma].
Hirano T; Tsuji T; Yamasaki H; Toyozumi Y; Arima N; Tsuda H
Rinsho Ketsueki; 2016 Feb; 57(2):171-4. PubMed ID: 26935635
[TBL] [Abstract][Full Text] [Related]
19. Protein kinase CK2 is widely expressed in follicular, Burkitt and diffuse large B-cell lymphomas and propels malignant B-cell growth.
Pizzi M; Piazza F; Agostinelli C; Fuligni F; Benvenuti P; Mandato E; Casellato A; Rugge M; Semenzato G; Pileri SA
Oncotarget; 2015 Mar; 6(9):6544-52. PubMed ID: 25788269
[TBL] [Abstract][Full Text] [Related]
20. The distinction between Burkitt lymphoma and diffuse large B-Cell lymphoma with c-myc rearrangement.
Nakamura N; Nakamine H; Tamaru J; Nakamura S; Yoshino T; Ohshima K; Abe M
Mod Pathol; 2002 Jul; 15(7):771-6. PubMed ID: 12118116
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
